Literature DB >> 6054919

Stellate ganglion block in treatment of total blindness due to quinine.

P P Bricknell, H G Middleton, A Hollingsworth, E M Evans.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6054919      PMCID: PMC1748685          DOI: 10.1136/bmj.4.5576.400

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  5 in total

1.  Transient loss of vision following use of quinine.

Authors:  C A TURTZ
Journal:  Am J Ophthalmol       Date:  1957-07       Impact factor: 5.258

2.  Toxic amblyopia.

Authors:  G I SCOTT
Journal:  Practitioner       Date:  1953-05

3.  Ocular symptoms of stellate ganglion block; its use in the treatment of occlusion of the central retinal artery.

Authors:  T O COSTON
Journal:  Am J Ophthalmol       Date:  1951-09       Impact factor: 5.258

4.  QUININE AMAUROSIS WITH REPORT OF A CASE.

Authors:  A J Ballantyne
Journal:  Br J Ophthalmol       Date:  1917-03       Impact factor: 4.638

5.  Stellate ganglion block; a new approach.

Authors:  R M DAVIES
Journal:  Anaesthesia       Date:  1952-07       Impact factor: 6.955

  5 in total
  3 in total

1.  The management of quinine-induced blindness.

Authors:  U Guly; P Driscoll
Journal:  Arch Emerg Med       Date:  1992-09

2.  Quinine amblyopia treated with stellate ganglion block.

Authors:  J L Bankes; J A Hayward; M B Jones
Journal:  Br Med J       Date:  1972-10-14

Review 3.  Blindness from quinine toxicity.

Authors:  P Bacon; D J Spalton; S E Smith
Journal:  Br J Ophthalmol       Date:  1988-03       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.